K17 ; Keratin Type I Cytoskeletal 17 ; Keratin-17 ; KRT17 ; PCHC1
Categories
Primary Antibodies
Cellular Localization
Cytoplasmic
Chromosome Location
17q21.2
Clonality
Monoclonal
Description
Cytokeratin 17 (CK17) is normally expressed in the basal cells of complex epithelia but not in stratified or simple epithelia. Antibody to CK17 is an excellent tool to distinguish myoepithelial cells from luminal epithelium of various glands such as mammary, sweat and salivary. CK17 is expressed in epithelial cells of various origins, such as bronchial epithelial cells and skin appendages. It may be considered as �epithelial stem cell� marker because CK17 Ab marks basal cell differentiation. CK17 is expressed in SCLC much higher than in LADC. Eighty-five percent of the triple negative breast carcinomas immunoreact with basal cytokeratins including anti-CK17. Also important is that cases of triple negative breast carcinoma with expression of CK17 show an aggressive clinical course. The histologic differentiation of ampullary cancer, intestinal vs. pancreatobiliary, is very important for treatment. Usually anti-CK17 and anti-MUC1 immunoreactivity represents pancreatobiliary subtype whereas anti-MUC2 and anti-CDX-2 positivity defines intestinal subtype.
Host
Mouse
Immunogen
The cytoskeletal fraction of rat colon epithelium
Isotype
IgG2b Kappa
Positive Control
T24 cells or Skin. Bladder or Cervix.
Reactivity
Human, Rat, Cow, Goat, Pig
Recombinant
FALSE
Regulatory
RUO
Swissprot
Q04695
Uniprot
2785
Gene Id
3872
Buffer
200μg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Concentration
1.0mg/ml
Description
There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
Applications
FACS, IF, WB, IHC-Ff
Description
(Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes); Optimal dilution for a specific application should be determined., FACS ; IF ; WB ; IHC-Ff
Dilution
FACS
0.5-1μg/million cells in 0.1ml
IF
1-2μg/ml
WB
0.5-1μg/ml
IHC-Ff
0.5-1μg/ml for 30 min at RT
No Description Available.
No Description Available.
Reviews of Anti-Cytokeratin 17 (KRT17) Antibody BHA10202831